138 related articles for article (PubMed ID: 7271878)
1. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
Inaba M; Fujikura R; Sakurai Y
Biochem Pharmacol; 1981 Jul; 30(13):1863-5. PubMed ID: 7271878
[No Abstract] [Full Text] [Related]
2. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia.
Inaba M; Sakurai Y
Cancer Lett; 1979 Dec; 8(2):111-5. PubMed ID: 555868
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells.
Inaba M; Watanabe T; Sugiyama Y
Jpn J Cancer Res; 1987 Apr; 78(4):397-404. PubMed ID: 3108219
[TBL] [Abstract][Full Text] [Related]
4. Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine.
Inaba M; Fujikura R; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1981 Aug; 30(15):2191-4. PubMed ID: 7295334
[No Abstract] [Full Text] [Related]
5. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
6. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
[TBL] [Abstract][Full Text] [Related]
7. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
8. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559
[TBL] [Abstract][Full Text] [Related]
9. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Inaba M; Nagashima K
Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
[TBL] [Abstract][Full Text] [Related]
10. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.
McGown AT; Ward TH; Fox BW
Cancer Chemother Pharmacol; 1983; 11(2):113-6. PubMed ID: 6627597
[TBL] [Abstract][Full Text] [Related]
12. Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells.
Gessner T; Vaughan LA; Beehler BC; Bartels CJ; Baker RM
Cancer Res; 1990 Jul; 50(13):3921-7. PubMed ID: 2112982
[TBL] [Abstract][Full Text] [Related]
13. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
Inaba M; Kobayashi H; Sakurai Y; Johnson RK
Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
[TBL] [Abstract][Full Text] [Related]
14. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
15. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
Chou TH; Kessel D
Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
[No Abstract] [Full Text] [Related]
16. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D; Schmidt H
Biochem Pharmacol; 1986 Feb; 35(4):673-8. PubMed ID: 3947398
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M
Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474
[TBL] [Abstract][Full Text] [Related]
18. [Features of developing resistance during combined use of antineoplastic agents, causing multiple drug resistance].
Goncharova SA; Demidova NS; Shiriaeva OA; Konovalova NP
Dokl Akad Nauk SSSR; 1991; 319(4):985-8. PubMed ID: 1800074
[No Abstract] [Full Text] [Related]
19. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Biochem Pharmacol; 1978; 27(17):2123-30. PubMed ID: 31880
[No Abstract] [Full Text] [Related]
20. Gamma interferon administration differently affects sensitive or doxorubicin resistant P388 leukemia cells; a relationship with antioxidant defenses?
Armata MG; Crescimanno M; Tapiero H; Rausa L; D'Alessandro N
Pharmacol Res; 1989; 21 Suppl 1():21-2. PubMed ID: 2517339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
